Research Paper Volume 16, Issue 1 pp 285—298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Figure 3. Expression of MAGE-A11 in different clinical features. (A) Clinical heat map of MAGE-A11 expression. (B) Box plot of MAGE-A11 expression under different clinical characteristics.